Identity
HGNC
LOCATION
19p13.2
LOCUSID
ALIAS
JNKK2,MAPKK7,MEK,MEK
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 5609
MIM: 603014
HGNC: 6847
Ensembl: ENSG00000076984
Variants:
dbSNP: 5609
ClinVar: 5609
TCGA: ENSG00000076984
COSMIC: MAP2K7
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000076984 | ENST00000397979 | O14733 |
| ENSG00000076984 | ENST00000397981 | O14733 |
| ENSG00000076984 | ENST00000397983 | O14733 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
PharmGKB
| Entity ID | Name | Type | Evidence | Association | PK | PD | PMIDs |
|---|---|---|---|---|---|---|---|
| PA283 | MAPK8 | Gene | Pathway | associated | 20124951, 23922006 | ||
| PA30592 | MAP3K1 | Gene | Pathway | associated | 23922006 | ||
| PA30616 | MAPK1 | Gene | Pathway | associated | 20124951 | ||
| PA30617 | MAPK10 | Gene | Pathway | associated | 20124951 | ||
| PA30618 | MAPK11 | Gene | Pathway | associated | 20124951 | ||
| PA30619 | MAPK12 | Gene | Pathway | associated | 20124951 | ||
| PA30620 | MAPK13 | Gene | Pathway | associated | 20124951 | ||
| PA30621 | MAPK14 | Gene | Pathway | associated | 20124951 | ||
| PA30622 | MAPK3 | Gene | Pathway | associated | 20124951 | ||
| PA30623 | MAPK4 | Gene | Pathway | associated | 20124951 | ||
| PA30624 | MAPK6 | Gene | Pathway | associated | 20124951 | ||
| PA30625 | MAPK7 | Gene | Pathway | associated | 20124951 | ||
| PA30630 | MAPK9 | Gene | Pathway | associated | 20124951 | ||
| PA34183 | RAF1 | Gene | Pathway | associated | 20124951 |
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38115586 | 2024 | Inhibition of MEK Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer. | 0 |
| 38141200 | 2024 | Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models. | 0 |
| 38261743 | 2024 | IL-17 promotes IL-18 production via the MEK/ERK/miR-4492 axis in osteoarthritis synovial fibroblasts. | 0 |
| 38115586 | 2024 | Inhibition of MEK Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer. | 0 |
| 38141200 | 2024 | Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models. | 0 |
| 38261743 | 2024 | IL-17 promotes IL-18 production via the MEK/ERK/miR-4492 axis in osteoarthritis synovial fibroblasts. | 0 |
| 36537752 | 2023 | Transcription factor ZNF488 accelerates cervical cancer progression through regulating the MEK/ERK signaling pathway. | 2 |
| 37154160 | 2023 | Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition. | 10 |
| 37686402 | 2023 | FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy. | 1 |
| 36537752 | 2023 | Transcription factor ZNF488 accelerates cervical cancer progression through regulating the MEK/ERK signaling pathway. | 2 |
| 37154160 | 2023 | Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition. | 10 |
| 37686402 | 2023 | FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy. | 1 |
| 34969747 | 2022 | Excellent Response to MEK Inhibition in an AGK-BRAF Gene Fusion Driven Carcinoma: Case Report and Literature Review. | 1 |
| 35594996 | 2022 | Low expression of PGC-1β and other mitochondrial biogenesis modulators in melanoma is associated with growth arrest and the induction of an immunosuppressive gene expression program dependent on MEK and IRF-1. | 3 |
| 34969747 | 2022 | Excellent Response to MEK Inhibition in an AGK-BRAF Gene Fusion Driven Carcinoma: Case Report and Literature Review. | 1 |
Citation
Dessen P
MAP2K7 (mitogen-activated protein kinase kinase 7)
Atlas Genet Cytogenet Oncol Haematol. 2003-08-01
Online version: http://atlasgeneticsoncology.org/gene/41275/map2k7-(mitogen-activated-protein-kinase-kinase-7)
